200-016 - CGM in diabetes - What are the recommendations?

Everything you need to know to help you choose Dexcom ONE for your patients living Diabetes. The Dexcom OONE real-time Continuous Glucose Monitoring (rt-CGM) system can help your patients on insulin, ages 2 years and older, get one step closer to better diabetes management compared with blood glucose monitoring alone - with zero finger pricks, or calibrations required. Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Everything you need to know to help you choose Dexcom G6 for your patients living Diabetes. The Dexcom G6 real-time Continuous Glucose Monitoring (rt-CGM) system can help your patients on insulin, ages 2 years and older, get one step closer to better diabetes management compared to blood glucose monitoring alone - with zero finger pricks,*or calibrations required. Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings

Everything you need to know to help you choose Dexcom G7 for your patients living Diabetes. The Dexcom G7 real-time Continuous Glucose Monitoring (rt-CGM) system can help your patients on insulin, ages 2 years and older, get one step closer to better diabetes management compared with blood glucose monitoring alone - with zero finger pricks, or calibrations required. Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom CLARITY allows healthcare professionals and patients to access clinically relevant glucose patterns, trends, and statistics—including the percentage of time that glucose levels are in low, target, and high ranges via a range of interactive reports. Use of Dexcom CLARITY can facilitate better conversations about a patient’s glucose insights during virtual or in-person visits. This Course will guide you through each Section of the Dexcom CLARITY Software, and provide you with top tips to help use Dexcom CLARITY as efficiently as possible as well as describe the DATAA model for interpretation of CGM data.

Everything you need to know to help you choose Dexcom ONE+ for your patients living Diabetes. The Dexcom ONE+ real-time Continuous Glucose Monitoring (rt-CGM) system can help your patients on insulin, ages 2 years and older, get one step closer to better diabetes management compared with blood glucose monitoring alone - with zero finger pricks, * or calibrations required. *Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom rtCGMSystems demonstrate clinical and quality-of-life outcomes across various ages. RCTs have shown that rtCGM led to greater improvements in A1C and TIR than IS-CGM1 and Dexcom CGM leads to improved clinical outcomes, including lowering A1C, reducing hyper-and hypoglycaemia, and increasing TIR2. This course will guide you through the wealth of high-level, randomised control trial evidence across all ages, from young children, through the older paediatrics, teenagers, younger adults, adults, and into senior years.

NICE1 was established on 1 April 1999, as part of the government’s wider strategy to address ‘unacceptable variations in performance and practice’ in the NHS and to remove a ‘lottery in care with patients being denied treatment available in neighbouring areas’2 This informative course will guide you through all Guidelines related to people living with diabetes and provide you with the information required to determine eligibility to rtCGM Systems. 1. NICE clinical guidelines cover the NHS in England, Wales and Northern Ireland 2. The Kings Fund, Briefing, NICE technology appraisals, 2008.

Living with diabetes is a numbers game, constantly chasing blood glucose numbers, dosing and monitoring. Blood glucose meters give a snapshot of glucose - a number at one point in time – with no indication of where that number is heading, up or down. Continuous Glucose Monitoring (CGM) is more like a story. A small sensor measures glucose levels just underneath the skin every five minutes, and a transmitter sends data wirelessly to a compatible smartphone, so people with diabetes can know their glucose number just with a glance at their phone, without finger pricks*. This course will help you understand the importance of early initiation of CGM for people with diabetes on insulin therapy and guide you through the clinical evidence supporting this.* Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Glucose alerts are an integral part of CGM systems and will alert the person living with Diabetes when their levels fall outside of present high and Low glucose levels, in order that they can take action. Customisable high and low glucose alerts offer people with diabetes the ability to set alert schedules and repeat alert functionality for discretion and flexibility. This course will guide Healthcare Professionals though the basic features and functions of Dexcom rtCGM system alerts and trend arrows. It will discuss the importance of educating people living with Diabetes and using rtCGM, on setting customised alerts levels to meet the needs of their own personalised care regime, to help them to take action to prevent or reduce the time spent in hypoglycaemia.

Hypoglycaemia is common in people with Type 1 diabetes (T1D). In fact, most people with T1D experience at least 1 or 2 episodes of mild hypoglycaemia a week. 1

Different kinds of activity and exercise have differing effects on glucose levels, and for anyone living with Diabetes, it is important to understand the impact of activity on glucose levels before, during and after exercise. This course will guide you through both the theory and practicalities of the impact of exercise on glucose levels for people living with Diabetes and gives useful information that you can provide to your patients during consultations.

Understanding how rtCGM can help to improve the lives of people living with diabetes is crucial to help application in clinical practice. This course will guide you through several real-life case studies using rtCGM, providing a detailed report of the problems, management and follow-up of individual patients.

Having confidence that a CGM device is accurate, is high priority for any Healthcare Professional initiating such technology with people living with Diabetes. This course will provide an overview of a review article on CGM Accuracy1 and provide objective information on CE marking indications for CGM devices and the clinical accuracy data supporting these indications.

Driving is an essential and intrinsic part of everyday living. For example, driving to and from the workplace, potentially driving at work, and just for everyday autonomy. Driving involves a series of complex skills, visual, spatial, memory, judgement, motor skills. Living with Diabetes can potentially affect these skills. DVLA regulations1 in relation to Diabetes focus on low blood sugar and hypoglycaemia. This informative course will provide information on the requirements for glucose testing when driving for people with Diabetes including information on when to inform driving authorities on changes in medical condition.

Good skin preparation is an essential component of applying a CGM sensor. This course will define best practice guidance on preparation of the skin prior to placing a CGM sensor, discuss the choices for placement of sensors, and provide recommendations for good skin care during sensor use.

Look at the specific challenges for people who are pregnant and live with diabetes or who are pregnant and diagnosed with gestational diabetes. Review of the risk factors for developing gestational diabetes as well as how inequalities can contribute to poorer outcomes for mother and child. Explore possible adverse outcomes and how the latest diabetes technologies, including CGM, Insulin pumps and pens compare in improvements in HbA1C based on the results of the 2017 CONCEPTT trial. An in-depth course that is a must for any HCP caring for pregnant patients with diabetes.

An overview of the latest hybrid closed loop (HCL) study in pregnancy by Dr. Helen Murphy and a fantastic patient perspective from some of the participants of the AIDAPT trial1 who experienced first hand pregnancy whilst managing their diabetes on a Hybrid Closed Loop (HCL) system. An in-depth course that is a must for any healthcare professional caring for pregnant patients with type 1 diabetes. 1. Lee T.M. et al, Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes, a multicentre randomized controlled trial. The New England Journal of Medicine. 2023, 389,1566-1578.

Want an in depth look into CGM use in children and young people and how best to support transitioning diabetes care? This course will take you through the recommendations for paediatric CGM use, the best time to start, key factors to consider and share best practice. We will also look at studies that show inequalities in diabetes care across socioeconomic groups.

An overview of the role that rt CGM can play in helping people with diabetes manage their food intake. We will explore the effects of carbohydrate, fats and proteins on glucose levels and how viewing CGM data using Dexcom Clarity‡ can support patients to make lifestyle choices. Including case studies on patients with Type 1 and Type 2 diabetes.

Dexcom ONE rtCGM system is available on an FP10 and can be prescribed from Primary Care. For Healthcare Professional's in the Primary Care setting, and caring for people living with Diabetes, this course will provide valuable implementation on the practical application of Dexcom ONE rtCGM. Join Su Down and Nadia Malik as they discuss the benefits and best practice associated with the use of Dexcom ONE rtCGM systems, including the ease of patients self-starting on this technology and how remote glucose monitoring can help primary care HCP's support people with Diabetes improve the management of their condition.

Due to changes in the NICE1 guidelines for people living with diabetes, technology is now established as an essential component of effective diabetes management for people living with Type 1 Diabetes. However since the update of NG282, many more people with type 2 Diabetes now have access to CGM when meeting certain criteria. Join Dr Kevin Fernando and Nadia Malik who discuss the benefits of rtCGM in all people living with Diabetes and on multiple daily insulin injections and gain insights into how people living with Diabetes can be empowered to self-monitor and self-manage their condition.

Did you know that the incidence of depression in people living with diabetes is double that in the general population.1 Learn how managing a condition like diabetes can put additional psychological burden on people with diabetes. Giving you ideas of how you can support the mental health of your patients. 1.Anderson et al. Diabetes Care 2001, 24(6), 1069-1078.

This course discusses a high-level overview of the existing evidence for using CGM in Type 2 diabetes. International clinical recommendations from ADA, AACE and EASD are examined where experts evaluated evidence to provide recommendations. Additionally, key systematic reviews, meta-analyses and clinical trials for CGM in Type 2 Diabetes are explored, including the landmark MOBILE study on the use of CGM in basal insulin users. Real-world evidence showing the benefits of CGM in this population is also discussed. The course concludes with a glance into the future and the need for continued evidence generation.

Join Dr Nanna Lind, lead author of the Steno2tech Study, as she discusses important outcomes of this research evaluating long-term effects of continuous glucose monitoring (CGM) versus capillary blood glucose monitoring (CBG) in adults living with insulin-treated type 2 diabetes (T2D) currently not achieving targets. This study found that CGM-correlated improvements were sustained over the long term, noting the benefits at six months were sustained at 12-months. In addition, researchers noted that CGM overcomes the limitations of traditional blood glucose monitoring–which can be painful, inconvenient, and fail to capture a complete glycaemic picture, given the intermittent nature of CBG.

This bite size module is a follow on from the Dexcom Education Hub course “Time in Range” an excellent metric for assessing risk of diabetes related complications1 and will introduce the concept of Time in Tight Range. This concept is an effort to encourage people with diabetes to achieve near normoglycemic ranges, and similar glucose levels to those living without diabetes. There is thought that by treating to this target, we could significantly reduce, or even eliminate the incidence of diabetes related complications2.

This course, focussed on pregnancy in those people living with Type 2 Diabetes will discuss the NICE guidelines related to pregnancy1, and in addition highlight the extra measure requested in this group by the Saving Babies Lives care bundle for reducing perinatal mortality2. The importance of pre-conception care will be discussed and data related to both maternal and neonatal outcomes highlighted. Finally, guidelines for, and real-life experience of using CGM in Type 2 diabetes during pregnancy, including lessons learnt will be covered.

This short course will provide an overview with practical tips and tricks for the use of continuous glucose monitoring (CGM) in people living with diabetes who are pregnant.  It will include discussion on the clinical set up and support for use of CGM (including both staff and patients), challenges that may be faced with using CGM in pregnancy, discuss equity for access to CGM and will be concluded with some top tips for the use of CGM in pregnancy.

As we await the final New NICE Medical Technology Appraisal on Hybrid Closed Loop (HCL) for those with Type 1 Diabetes, Dexcom have worked with the clinical experts at the Diabetes Technology Network (DTN) to launch a series of education modules encompassing everything you need to know about Hybrid Closed Loop technology. This course ‘Introduction to HCL’ is the first step to gaining confidence in understanding and using HCL systems to support diabetes management.

Did you know Dexcom offers the most connected rtCGM family of systems?* Real-time continuous glucose monitoring (rtCGM) with Dexcom systems and connected partners can help remove a lot of the burden of diabetes management and treatment decisions. Dexcom rtCGM systems can connect with, Smart Insulin Pens (via Glooko®) ⴕ,Insulin pumps in hybrid closed-loop systems (Dexcom G6 only),Third party diabetes management apps Helping people with diabetes see the direct impact of treatment decisions and activity on their glucose levels and giving them tailored and motivating content to keep them on track.

This bite size module will help you to understand the benefits of using CGM in the Type 2 diabetes population. Covering NG28 (NICE Guidance for Type 2 diabetes in adults1) this module will also discuss the limitations of SMBG and HbA1c for reviewing diabetes management and the CGM metrics and Dexcom Clarity report that can support management.

This bite size module will help you to understand the benefits of using CGM in the Type 2 diabetes population. Covering NG28 (NICE Guidance for Type 2 diabetes in adults1) this module will also discuss the limitations of SMBG and HbA1c for reviewing diabetes management and the CGM metrics and Dexcom Clarity report that can support management.

This informative course will provide primary Care Physicians the essential information they need to know when caring for people living with diabetes who are utilising Hybrid Closed Loop (HCL) insulin pump systems. Although care of this group primarily sits within specialist multi-disciplinary teams, the primary care HCP’s involved in the treatment of people using HCL systems should understand the benefits of HCL systems, understand sick day rules for this population, and also have awareness of essential supplies that are required on repeat prescription.